glp 1 and mood changes Association between GLP-1 receptor agonist use worsening mental illness in people with depression and anxiety in Sweden: a national cohort study glp-1 and mood Receptor Agonists

Blockade of CD26 signaling inhibits human osteoclast development

"FDA approves first treatment to increase pain-free light exposure in patients with a rare disorder" (Press release)

It feeds on prebiotics like polyphenols and fiber to produce butyrate, which ultimately supports our bodys natural production of GLP-1, the hormone that helps regulate appetite and cravings (aka the hormone everyone is talking about these days as it relates to GLP-1 agonists)

Meier JJ, Kemmeries G, Holst JJ, Nauck MA

A Brain Reward Circuit Inhibited by Next-Generation Weight-Loss Drugs in Mice

Dosing increases may be needed to maintain effectiveness Retatrutide Retatrutide is a once-weekly injectable peptide designed to support weight loss by activating three key metabolic pathways in the body: GLP-1: helps control appetite and slow digestion GIP: enhances insulin response and metabolic balance Glucagon receptor: increases energy use and supports fat burning By targeting all three pathways simultaneously, Retatrutide is considered a triple-agonist therapy , offering a more comprehensive approach to weight management